Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
243.52 |
212.83 |
224.62 |
344.03 |
364.39 |
Operating profit |
72.14 |
68.14 |
97.35 |
169.88 |
174.63 |
Interest |
2.29 |
1.27 |
0.50 |
1.15 |
2.29 |
Gross profit |
86.72 |
80.84 |
111.05 |
178.79 |
183.09 |
EPS (Rs) |
2.10 |
2.06 |
2.94 |
4.88 |
5.11 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
16.87 |
13.97 |
14.20 |
10.06 |
10.75 |
Stock adjustment |
17.02 |
6.39 |
8.97 |
21.50 |
20.88 |
Raw material |
63.16 |
60.65 |
46.95 |
77.62 |
89.57 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
37.10 |
30.62 |
26.51 |
26.27 |
22.90 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
2.01 |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
54.10 |
47.03 |
44.83 |
48.75 |
54.41 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
15.66 |
11.33 |
10.48 |
11.15 |
10.63 |
Taxation |
17.62 |
17.14 |
25.84 |
43.35 |
42.30 |
Net profit / loss |
53.43 |
52.36 |
74.73 |
124.29 |
130.16 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
25.46 |
25.46 |
25.46 |
25.46 |
25.46 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
29.62 |
32.01 |
43.34 |
49.38 |
47.92 |
GPM (%) |
33.30 |
35.64 |
46.50 |
50.49 |
48.81 |
NPM (%) |
20.52 |
23.09 |
31.29 |
35.10 |
34.70 |